Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-12
1997-01-21
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 852, 514 2, 514 21, A61K 3807, A61K 3800
Patent
active
055959733
ABSTRACT:
A method of promoting regeneration of hemopoietic cells in a subject undergoing chemotherapy or radiotherapy, which method includes the steps of (i) administering to the subject a first amount of a hemopoiesis inhibitory factor, the first amount being effective to reduce the proliferation of hemopoietic cells during the chemotherapy or radiotherapy; and (ii) after the chemotherapy or radiotherapy, administering to the subject a second amount of a hemopoiesis growth factor, the second amount being effective to stimulate the proliferation of hemopoietic cells.
REFERENCES:
patent: 5114926 (1992-05-01), Frindel et al.
Castelli et al., "Protective, Restorative, and Therapeutic Properties of Recombinant Human IL-1 in Rodent Models", The Journal of Immunology 140:3830-3837, 1988.
Fibbe, et al., "A Single Low Dose of Human Recombinant Interleukin 1 Accelerates the Recovery of Neutrophils in Mice with Cyclophosphamide-induced Neutropenia", Experimental Hematology 17:805-808, 1989.
Futami et al., "Chemoprotective Effects of Recombinant Human IL-1.alpha. In Cyclophosphamide-Treated Normal and Tumor-Bearing Mice", The Journal of Immunology 145:4121-4130, 1990.
Gianni et al., "Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Reduces Hematologic Toxicity and Widens Clinical Applicability of . . . ", Journal of Clinical Oncology 8:768-778, 1990.
Guigon et al., "Convenient Source of CFU-s Inhibitors: The Fetal Calf Liver", Cell Tissue Kinet 17:49-55, 1984.
Guigon et al., "Effects of CFU-S Inhibitors on Murine Bone Marrow During ARA-C Treatment--1. Effects On Stem Cells", Leukemia Research 4:385-391, 1980.
Lenfant et al., "Inhibitor of Hematopoietic Pluripotent Stem Cell Proliferation: Purification and Determination of its Structure", Proc. Nat. Acad. Sci. USA 86:779-782, 1989.
Moore et al., "Synergy of Interleukin 1 and Granulocyte colony-Stimulating Factor: In vivo Stimulation of Stem-Cell Recovery and Hematopoietic Regeneration . . . ", Proc. Natl. Acad. Sci. USA 84:7134-7138, 1987.
Neta et al., "Interleukin 1 is a Radioprotector", The Journal of Immunology 136:2483-2485, 1986.
Oppenheim et al., "Interleukin-1 Enhances Survival of Lethally Irradiated Mice Treated With Allogeneic Bone Marrow Cells", Blood 74:2257-2263, 1989.
Schuening et al., "Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Hematopoiesis of Normal Dogs & on Hematopoietic Recovery After Otherwise Lethal Total Body . . . ", Blood 74:1308-1313, 1989.
Steward et al., "Clinical Applications of Myeloid Colony Stimulating Factors", Cancer Treatment Reviews 17:77-87, 1990.
Tanikawa et al., "Effects of Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF) and Recombinant Granulocyte-Macrophage Colony-Stimulating . . . ", Exp. Hemotol 17:883-888, 1989.
Thierry et al., "Synthesis and Activity of NAcSerAspLysPro Analogues on Cellular Interactions Between T-Cell and Erythrocytes in Rosette Formation", J. Med. Chem. 33:2122-2127, 1990.
Till et al., "A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells", Radiation Research 14:213-222, 1961.
Tubiana et al., "Ways of Minimizing Hematopoietic Damage Induced by Radiation and Cytostatic Drugs -The Possible Role of Inhibitors", Radiotherapy and Oncology 29:1-17, 1993.
Wdzieczak-Bakala et al., "Further Purification of a CFU-S Inhibitor: In vivo Effects After Cytosine Arabinoside Treatment", Biomedicine & Pharmacotherapy 37:467-471, 1983.
Welte et al., "Recombinant Human Granulocyte Colony-Stimulating Factor . . . ", J. Exp. Med. 165:941-948, 1987.
Robinson et al., "The Molecular Specificity of Action of the Tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the Control of Hematopoietic Stem Cell Proliferation", Stem Cells 11:422-427, 1993.
Paukovits et al., "Pre-CFU-S Quiescence and Stem Cell Exhaustion After Cytostatic Drug Treatment: Protective Effects of the Inhibitory Peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK)", Blood 81:1755-1761, 1993.
Achutamurthy Ponnathapura
Biomeasure Incorporated
McGowan William E.
LandOfFree
Protection of hemopoietic cells during chemotherapy or radiother does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protection of hemopoietic cells during chemotherapy or radiother, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection of hemopoietic cells during chemotherapy or radiother will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324266